A phase 1 dose-escalation and -expansion study of AFN0328, a novel mRNA-based immunotherapy, in patients with HPV16/18-associated high-grade squamous intraepithelial lesions.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162484556
Cites:
Cited by:
Related to:
